NEC Bio B.V.
Breadcrumb navigation
About Us
NEC Bio B.V.
NEC Bio aims to couple state-of-the-art AI technologies with biomedical sciences to drive drug discovery and development, which will help people to live healthier, happier lives.
By pursuing both AI-powered drug design and established experimental methods, we can substantially accelerate the preclinical drug discovery stage to enable the rapid delivery of new treatments to patients worldwide.
NEC Bio is a subsidiary of NEC Japan, a world-renowned AI and ICT technology firm. In March 2023, NEC Japan established a holding company NEC Bio B.V in Hilversum, Netherlands, that manages two companies, NEC OncoImmunity in Norway and NEC Bio Therapeutics in Germany.
The main focus of NEC Bio is to unify and streamline AI-powered drug research and development and to strengthen NEC’s global position in this area.
| Registered Office |  Marathon 2, 1213 PH Hilversum, The Netherlands |
|---|---|
| Representative | Akira Kitamura, Chief Executive Officer |
| Parent Company | NEC Corporation |
Contact UsNEC OncoImmunity AS
NEC OncoImmunity uses leading-edge research and development practices to develop world class AI technology that will bring novel treatments to patients across the globe in the fields of oncology and infectious diseases.
| Visit Address | Forskningsparken (Oslo Science Park), Gaustadalleen 21, 0349 Oslo, Norway |
|---|---|
| Registered Office | Oslo Cancer Cluster, Innovation Park, Ullernchausséen 64, 0379, Oslo, Norway |
| Representative | Dr. Saverio Niccolini, Chief Executive Officer |
| Parent Company | NEC Bio B.V. |
NEC Bio Therapeutics GmbH
NEC Bio Therapeutics focuses on clinical strategy and development and the planning and execution of clinical trials for cancer treatments.
| Registered Office | Landteilstr. 24 68163 Mannheim, Germany |
|---|---|
| Representative | Dr. Heinz Lubenau, Chief Executive Officer |
| Parent Company | NEC Bio B.V. |
Organizational Structure
NEC Corporation
| Head Office | 7-1, Shiba 5-chome, Minato-ku, Tokyo 108-8001 Japan |
|---|---|
| Representative | Takayuki Morita, President and CEO (Representative Executive Officer), Member of the Board |
NEC Website